High Tower Advisors, LLC Vista Gen Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.09 - $4.8 $3,240 - $172,800	-36,000 Reduced 22.89%	121,273 $12,000
Q3 2022 Nov 09, 2022	SELL	$0.14 - $4.8 $672 - $23,064	-4,805 Reduced 2.96%	157,273 $23,000
Q1 2022 May 12, 2022	BUY	$1.14 - $2.09 $29,639 - $54,339	26,000 Added 19.11%	162,078 $200,000
Q2 2021 Aug 06, 2021	BUY	$1.96 - $3.15 $19,600 - $31,500	10,000 Added 7.93%	136,078 $429,000
Q1 2021 May 10, 2021	BUY	$1.89 - $2.96 $238,287 - $373,190	126,078 New	126,078 $269,000
Q4 2020 Feb 10, 2021	SELL	$0.65 - $1.94 $86,013 - $256,716	-132,328 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$0.46 - $1.29 $11 - $32	-25 Reduced 0.02%	132,328 $142,000
Q2 2019 Aug 13, 2019	BUY	$0.54 - $1.33 $54,706 - $134,739	101,308 Added 326.33%	132,353 $96,000
Q1 2019 May 15, 2019	SELL	$1.1 - $1.76 $275 - $440	-250 Reduced 0.8%	31,045 $39,000
Q4 2018 Feb 14, 2019	BUY	$1.28 - $2.24 $9,688 - $16,954	7,569 Added 31.9%	31,295 $46,000
Q2 2018 Aug 14, 2018	BUY	$0.85 - $1.5 $2,190 - $3,865	2,577 Added 12.18%	23,726 $32,000
Q1 2018 May 15, 2018	BUY	$0.91 - $1.73 $849 - $1,615	934 Added 4.62%	21,149 $19,000
Q2 2017 Aug 14, 2017	BUY	N/A	20,215	20,215 $38,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.